These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 27681789)
1. Michael Rosenblatt. Nat Rev Drug Discov; 2016 Sep; 15(10):672. PubMed ID: 27681789 [No Abstract] [Full Text] [Related]
2. Q&A: Bernard Munos. Bender E Nature; 2016 May; 533(7602):S59. PubMed ID: 27167392 [No Abstract] [Full Text] [Related]
3. Fix the antibiotics pipeline. Cooper MA; Shlaes D Nature; 2011 Apr; 472(7341):32. PubMed ID: 21475175 [No Abstract] [Full Text] [Related]
4. [Open innovation and licensing in the pharmaceutical industry]. Yamasaki M Nihon Yakurigaku Zasshi; 2013 Jul; 142(1):28-31. PubMed ID: 23842225 [No Abstract] [Full Text] [Related]
5. [Open innovation for Japanese pharmaceutical companies]. Hoshino T Nihon Yakurigaku Zasshi; 2013 Oct; 142(4):184-9. PubMed ID: 24107523 [No Abstract] [Full Text] [Related]
6. The current state of drug discovery and what it might take to improve drug discovery outcomes and approval successes. Turner MJ Drug Discov Today; 2015 Aug; 20(8):917-9. PubMed ID: 26100736 [No Abstract] [Full Text] [Related]
7. Ian Tomlinson. Tomlinson I Nat Rev Drug Discov; 2016 Mar; 15(3):154. PubMed ID: 26893183 [No Abstract] [Full Text] [Related]
8. Open innovation: share or die.. Talaga P Drug Discov Today; 2009 Nov; 14(21-22):1003-5. PubMed ID: 19778629 [No Abstract] [Full Text] [Related]
9. Drug discovery for the developing world: progress at the Novartis Institute for Tropical Diseases. Jones CL; Yeung BK; Manjunatha U; Shi PY; Bodenreider C; Diagana TT Nat Rev Drug Discov; 2015 Jun; 14(6):442-4. PubMed ID: 26027536 [No Abstract] [Full Text] [Related]
11. Bank tests drug development waters. Mullard A Nat Rev Drug Discov; 2014 Sep; 13(9):643-4. PubMed ID: 25176422 [No Abstract] [Full Text] [Related]
12. Biopharma deal-making in 2016. Micklus A; Muntner S Nat Rev Drug Discov; 2017 Mar; 16(3):161-162. PubMed ID: 28209988 [No Abstract] [Full Text] [Related]
13. European lead factory opens for business. Mullard A Nat Rev Drug Discov; 2013 Mar; 12(3):173-5. PubMed ID: 23449292 [No Abstract] [Full Text] [Related]
14. The critical impact of time discounting on economic incentives to overcome the antibiotic market failure. Spellberg B; Sharma P; Rex JH Nat Rev Drug Discov; 2012 Feb; 11(2):168. PubMed ID: 22293569 [No Abstract] [Full Text] [Related]
16. Ask the experts: future of the pharmaceutical industry. Interview by Future Medicinal Chemistry. Cottens S; Eaton M; Fuhr J; Geary S; Johnson DS; Li G; Raveglia L; Robertson GM; Westwell A Future Med Chem; 2011 Nov; 3(15):1863-72. PubMed ID: 22023030 [TBL] [Abstract][Full Text] [Related]
17. David Haslam. Interview by Asher Mullard. Haslam D Nat Rev Drug Discov; 2013 Jul; 12(7):500. PubMed ID: 23764976 [No Abstract] [Full Text] [Related]